Company
Merck
- Episodes
- 7
- Share
- 0.8%
- Shows
- 6
- Net sentiment
- –
Bullish 0Mixed 2Neutral 5Bearish 0
5 weeks
Share of each week's episodes naming it, and net sentiment.
0%2%4%
Sep 21Sep 28Oct 5Oct 12Oct 19
Net sentiment
−10+1
Sep 21Sep 28Oct 5Oct 12Oct 19
The episodes that named it
Why each one was bullish, bearish or in between on Merck. Longest episodes first.
Mixed 2
- Positive phase three melanoma data, but the stock has been weak and Keytruda's patent expiry looms.9AM HOUR: Apple iPhone Duo Hits Stores, Tech Extends Sell-off, Merck CEO "First on CNBC" 10/23/26 · Squawk on the Street · Oct 23
- Co-developer of the cancer vaccine; investors reacted negatively to the leaked data.Why Calling a Democrat a Socialist Isn’t the Insult It Once Was · WSJ What’s News · Oct 23
Neutral 5
- Its drug Keytruda is paired with Moderna's cancer vaccine in the trial.Moderna Drama, WSJ Mansion Section, Genetically Engineered Military Dogs | Thomas Wright, Kyle Schiller, Steven Schwartz · TBPN · Oct 23
- Its drug Keytruda is used in combination with Moderna's cancer treatment.Why Moderna Tanked, MSG Employees Duped By Their Boss, The Mansion Section | Diet TBPN · TBPN · Oct 23
- Mentioned as partner whose PD-1 immunotherapy Keytruda is the current melanoma standard.Moderna’s Dr. Stephen Hoge on AI and the Future of Healthcare · Inside Blackstone · Oct 20
- Partner on the melanoma vaccine tied to Keytruda, with no stock move discussed.OpenAI’s Next Round, SpaceX’s Big Plans, & Reforming the MBA Program 10/23/26 · Squawk Pod · Oct 23
- Partner with Moderna on the skin cancer vaccine study.Tech stocks wobble; Russia and Ukraine exchange attacks, and more · The World in Brief from The Economist · Oct 23
Themes, sentiment and reasons are AI-written paraphrases, checked so they never quote an episode. They may contain errors. Not investment advice. Episodes remain the property of their creators.
Briefs like this, for everything you follow.
Ethmos puts research agents on your coverage universe — every debate that touches your names, every executive appearance you'd have missed — and files briefs every morning.
Start free14-day free trial